SCHEMBL22479770

SCHEMBL22479770

CSC(C)(C)COC(=O)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 2/20 0.31
HSD17B10 Q99714 1/20 0.31
HTT P42858 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
MMP8 P22894 1/20 0.31
TSHR P16473 2/20 0.30
CYP3A4 P08684 1/20 0.30
NFKB1 P19838 1/20 0.30
ADRA1A P35348 1/20 0.30
RAB9A P51151 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23463158 0.81 ALDH1A1 (0.35) ALDH1A1POLBMAPTHTTGRIN2D
SCHEMBL21468611 0.78 ALDH1A1 (0.33) ALDH1A1POLBMAPT
SCHEMBL10172752 0.77 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10TSHRRAB9A
SCHEMBL882160 0.77 ALDH1A1 (0.40) ALDH1A1POLBMAPTLMNAHSD17B10
SCHEMBL7934757 0.77 ALDH1A1 (0.40) ALDH1A1POLBMAPTLMNAHSD17B10
SCHEMBL15933348 0.76 ALDH1A1 (0.37) ALDH1A1POLBMAPTLMNAHSD17B10
SCHEMBL10955234 0.75 ALDH1A1 (0.42) ALDH1A1POLBMAPTLMNAHSD17B10
SCHEMBL13346809 0.74 ALDH1A1 (0.41) ALDH1A1POLBMAPTHTTGRIN2D
SCHEMBL13346798 0.73 THRB (0.40) ALDH1A1POLBMAPTHTTCYP3A4
SCHEMBL24502636 0.73 ALDH1A1 (0.38) ALDH1A1POLBMAPTHTTGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200306243-A1 COMPOUNDS AND CONJUGATES THEREOF MEDIMMUNE LIMITED (GB) 2020-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200306243-A1 COMPOUNDS AND CONJUGATES THEREOF TOP2A, TOP1, TOP2B ALDH1A1 1742/4885POLB 169/4885MAPT 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.